Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC-12 cells. by Lindenbaum, M.H. et al.
THE JOURNAL OF BtOLOGICAL CHEMISTRY 
0 1988 by The American Society for Biochemistry and Molecular Biology, Inc. 
Vol. 263, No. 12, Issue of April 25, pp. 56624667,1988 
Printed in U. S. A. 
Transcriptional and Post-transcriptional Effects of Nerve 
Growth  Factor  on Expression of the Three Neurofilament 
Subunits in  PC-12 Cells* 
(Received  for publication, November 3, 1987) 
Michael  H.  LindenbaumS, Salvatore Carbonettot, Frank  Grosveldq, David Flavellll, and 
Walter E. MushynskiII 
From the  Department of Biochemistry,  McGill  University and §Neuroscience  Unit,  Montreal  General  Hospital  Research 
Institute, Montreal, Quebec, Canada, H3G 1 Y6, and the lhboratory of Gene Structure and Expression, National Institute for 
Medical Research, Mill  Hill, London, United  Kingdom 
Nerve growth factor (NGF) is known to increase the 
levels of neurofilament proteins in PC-12 pheochro- 
mocytoma cells. In this report, we show that the three 
neurofilament subunits, NF-L, NF-M,  and NF-H, are 
not induced coordinately. NF-H  accumulated only  after 
longer term NGF treatment than required for NF-L 
and NF-M. While  NGF treatment resulted in  12- and 
14-fold increases in NF-L and NF-M mRNA levels, 
respectively,  over a 14-day period, no increase in the 
level of NF-H mRNA was observed. This indicated that 
in PC-12 cells, control of NF-H expression by NGF 
may  occur at the post-transcriptional level. NGF ap- 
peared to have no effect on the stability of NF-L 
mRNA, although it increased the stability of NF-M 
mRNA relative  to that in control PC-12  cells. Analysis 
of the effect of NGF on the transcription of neurofila- 
ment genes showed 4- and 5-fold increases in the rates 
of NF-L and NF-M gene transcription, respectively, 
and no increase in the rate of NF-H gene transcription. 
Taken together these results demonstrate that NGF 
stimulates the expression of individual neurofilament 
subunits at the transcriptional and/or post-transcrip- 
tional levels. 
Neurofilaments (NF)’ are the intermediate filament sub- 
class expressed  specifically in  neurons.  Mammalian  NFs  are 
composed of three  subunits  having  apparent molecular  masses 
by SDS-PAGE of 70 kDa  (NF-L),  150  kDa  (NF-M),  and 200 
kDa (NF-H) (1). The NF subunits are encoded by unique 
genes (2-8), with mice having  mRNA  transcripts of 2.5 and 
4.0 kb for NF-L, 3.0 kb for NF-M, and 4.5 kb for NF-H 
mRNA (5). It  is  thought  that  the 4.0-kb NF-L  mRNA species 
arises from the read-through of a tandem polyadenylation 
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signal  in  the  NF-L gene (6)  as  has  been  demonstrated  to occur 
during  vimentin gene transcription  (9). 
While  other  intermediate  filament subclasses share  similar 
gene structures, indicative of a common ancestor (10-14), 
they show little  structural homology with NF genes (2, 4, 5, 
7,8).  It  appears  that  NF genes diverged at an  early  stage from 
the  rest of the  intermediate  filament gene family (2, 4, 5, 7, 
8). N F  genes do  share  one  important  characteristic  with  other 
intermediate  filament genes, namely, their tissue-specific 
expression during development  (for reviews see Refs. 15, 16). 
NF proteins can be detected in cells with an identifiably 
neuronal  phenotype at early  stages of embryogenesis (17,18). 
At the level of NF gene transcription,  mRNA for NF-L  and 
NF-M  subunits  can be detected  in developing mouse brains 
as early as 11 days of gestation (5). NF-H mRNA, on the 
other  hand, was detectable a t  significant levels only postna- 
tally (5). Postnatal  onset of NF-H expression, at  the  protein 
level, has also been demonstrated (19-21). However, these 
results remain controversial in light of some evidence for 
prenatal expression of NF-H  in  central nervous system  and 
peripheral nervous system tissue (18). These discrepancies 
may be due  to differences in methodology, for example the 
use of antibodies  that  distinguish between fully phosphoryl- 
ated  and  hypophosphorylated  variants of NF-H (22-24), or 
else they may represent variations in the pattern of NF 
expression in  different  types of neurons  within  the  brain. A 
better  understanding of how the expression of NF genes is 
regulated might allow for  a  reconciliation of these  disparate 
observations. 
The  PC-12 cell line,  which is derived from a rat  pheochro- 
mocytoma,  provides a relatively  simple,  homogeneous system 
for studying  various  aspects of neuronal  differentiation (25- 
27). When cultured in growth medium supplemented with 
nerve growth factor  (NGF),  these cells  acquire  a phenotype 
resembling that of peripheral  neurons  (27), while cells main- 
tained  in medium  lacking NGF  remain  undifferentiated.  Pre- 
vious studies  have  demonstrated  that  PC-12 cells express  the 
NF  triplet (28-31, 52)  and  that  treatment of these cells with 
NGF  stimulates  the  biosynthesis  and  phosphorylation f NF 
subunits, as well as increasing the metabolic stability of the 
subunits (28, 29, 31). NGF-treated  PC-12 cells  express rela- 
tively  large amounts of NF-L  and  NF-M  but low levels of NF- 
H (29-31) and appear to represent an interesting model 
system for studying the regulation of differential NF gene 
expression. The  present communication examines  the effect 
of NGF  treatment  on  NF  subunit expression in  PC-12 cells, 
both at the protein and transcriptional levels. The results 
show that NGF increases both the transcriptional activity 
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and  mRNA levels for NF-L  and  NF-M,  but  not for NF-H. 
Apparently,  the genes coding for the  three  NF  subunits  are 
not expressed  coordinately. 
MATERIALS AND METHODS 
PC-I2 Cell Culture-PC-12 cells were obtained from Dr. L. A. 
Greene (New York University Medical School) and were maintained 
according to published procedures (27) as described previously (31). 
Cells were harvested by trypsinization, washed free of trypsin, and 
plated at  densities of 5 X lo6 cells/l50-mm dish. Cultures were 
maintained  in  either complete medium consisting of 85% Dulbecco's 
modified Eagle's medium, 10% heat-inactivated horse serum (Gibco), 
5% fetal bovine serum (Gibco), and antibiotics, or complete medium 
plus 150 ng/ml7S NGF (Dr. R. Stach,  State University of  New York, 
Syracuse). In some experiments actinomycin D (ACTD, Boehringer 
Mannheim, Canada) was added to the medium at  5 pg/ml final 
concentration for periods up to 25  h. 
Immumblot Analysis of NF Proteins from PC-12 Cell Cytoskek- 
tons-PC-12 cells were maintained in complete medium or complete 
medium plus NGF for up to 14 days. At  1, 4, 8, and 14 days, cells 
were harvested and cytoskeletons extracted and solubilized as de- 
scribed (31). Protein  concentrations were determined by a dye-bind- 
ing assay (32) and equal amounts of protein (5 pg) from the solubilized 
cytoskeletons were fractionated by SDS-polyacrylamide gel electro- 
phoresis (SDS-PAGE) (33) using an 8% separating gel. The resolved 
proteins were then transferred electrophoretically (34) to a nitrocel- 
lulose membrane (0.1 p~ pore size; pH 79, Schleicher & Schuell) for 
3  h a t  1 A and 25 V. The resultant nitrocellulose membrane blot was 
probed with a  mixture of affinity-purified antibodies against the  three 
NF subunits and antibody-binding bands were visualized by 1251- 
protein A binding (Du Pont-New  England Nuclear, Canada, 10 pCi/ 
pg)  following autoradiography after exposure for 1-4 days to XAR 5 
x-ray film (Eastman Kodak) as previously described (35). 
Northern Blot Analysis of NF mRNA from PC-12 Cells-PC-12 
cells were  grown either  in complete medium or for 1, 4, or 14 days in 
NGF-containing medium. At  the appropriate times, plates were 
washed 3 times with ice-cold phosphate-buffered saline, cells har- 
vested by scraping with a rubber policeman, and  total RNA extracted 
and purified in  6 M guanidine hydrochloride as previously described 
(36). The mRNA content of each sample was estimated by use of a 
[3H]poly(U) binding assay (37). RNA samples, containing 400 ng of 
poly(A)'  RNA,  were fractionated by electrophoresis on  a 1% formal- 
dehyde-agarose gel (38) and were transferred to a nylon membrane 
(Biotrans; ICN, Canada) by capillary transfer according to manufac- 
turer's  instructions. The Northern blots were probed with a 0.3-kb 
mouse cDNA to NF-L  (5),  a 0.6-kh mouse cDNA to NF-M (5), a 1.2- 
kb fragment of the mouse NF-H gene (5), or a 1.7-kb mouse cDNA 
to NF-H. Probes were labeled by the random primer labeling tech- 
nique (39, 40) to specific activities of  -10' cpm/mg. Blots were 
hybridized by incubation at  65  "C for 2  h  in  a solution consisting of 
1 M NaCl, 1% SDS, 10% dextran  sulfate (P-L Pharmacia,  Canada), 
100 pg/ml sheared,  denatured salmon sperm DNA and  the appropriate 
denatured probe. Washes were performed to stringencies of 0.1 X 
SSC at  65 "C, except when blots were hybridized with the genomic 
NF-H probe which  were washed to stringencies of 0.5 X SSC at 65  "C. 
The damp blots were wrapped in clear plastic wrap and exposed at 
-70 "C to x-ray film (note above) with intensifying screens (Cronex 
Lightning Plus; Du Pont) (41) for up  to 7 days. Blots were subse- 
quently deprobed prior to  the next round of hybridization, by incu- 
bation for 30 min at  65 "C in  a solution consisting of 96% deionized 
formamide, 10 mM Tris-HC1, pH 7.5, and 10 mM EDTA, followed by 
a brief rinse with 1 X SSC. 
Nuclear Run-off  Assays-Nuclei from cells (1 X lo') maintained  in 
control medium or in NGF-supplemented medium for 8 days were 
isolated and nuclear run-off transcription assays were performed as 
previously described (42). Linearized plasmid DNAs containing  ap- 
propriate  inserts were denatured by incubating  in 0.3 M NaOH, at  
70 "C for 60 min. The denatured DNA was neutralized by addition of 
ammonium acetate to 1 M and was bound to the nitrocellulose 
membrane using a  slot-blot  filtration manifold (Bethesda Research 
Laboratories-GIBCO). The wells of the apparatus were washed 3 
times with 1 M NH,OAc then  the membrane was  removed, dried, and 
baked in vacuo at  80 "C for 2 h. Hybridizations, using lo7 cpm/ml of 
input RNA, as well as subsequent washing steps were performed as 
previously described (42). The plasmids used in this study include a 
2.7-kb  cDNA insert to mouse NF-L (5), a 0.6-kb cDNA to mouse NF- 
M (5), and a 1.7-kb cDNA to mouse NF-H,  all  in pUC 8 as well as  a 
cDNA to actin in pBR322 (pam91, Ref. 44). Controls consisted of 
pUC 18, and pBR322 DNA, without inserts. 
Northern Blot Analysis of  mRNA from Actinomycin D-treated PC- 
12 Cells-PC-12 cells were grown in complete medium or medium 
supplemented with NGF for 5-6 days. At  that time ACTD at  a final 
concentration of 5 pg/ml was added to  the medium. At  0, 5, 10, 15, 
and 25 h  after ACTD administration RNA  was isolated from the cells 
and subjected to Northern analysis. Hybridizations with cDNA 
probes to each NF subunit were performed sequentially on the same 
Northern blot as described above. Hybridization signals on autora- 
diographs were quantified using a laser beam densitometer (LKB). 
RESULTS 
The effect of NGF on the levels of NF proteins in the 
cytoskeletal fraction of PC-12 cells was examined by Western 
blot analysis. The  results  in Fig. 1 show a dramatic increase 
in  the levels of NF-L  and  NF-M in PC-12 cells after 4 days 
of treatment  with NGF.  Although NF-L  and  NF-M  are only 
barely visible in  the  control  extract,  there  is a basal level of 
immunoreacting material in cells grown in the absence of 
NGF  (see for  example Ref. 31). While the increase  in NF-L 
and  NF-M levels occurred  simultaneously, the level of NF-H 
increased much more slowly. The  latter  subunit was barely 
detectable after 4 days of exposure to NGF but showed a 
steady  increase  thereafter. By 14 days of NGF  treatment,  NF- 
H immunoreactivity reached significant levels. The NF-H 
band  appeared  to be  somewhat diffuse, likely reflecting the 
presence of NF-H  in a variety of phosphorylation  states (31, 
45) since  the polyclonal antibodies used in  this  study recog- 
nized both fully phosphorylated  and hypophosphorylated var- 
iants of the  NF  subunits (31). 
In  light of the  magnitude of the  NGF effect on  the levels of 
NF  subunits  in PC-12 cells, we determined  whether  NGF also 
affected the levels of NF mRNA. The results of Northern 
analyses  are shown in Fig. 2. In  agreement  with  observations 
by others (46), Fig. 2.4 shows an  NGF-stimulated increase in 
N F-H- 
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0 1 4 8 14 days 
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FIG. 1. Western blot analysis of PC-12 cytoskeleton-asso- 
ciated NF proteins in PC-12 cells. Cytoskeleton proteins of 
control PC-12 cells (0 day) or PC-12 cells grown in NGF-containing 
medium for 1, 4, 8, or 14 days were resolved by SDS-PAGE and 
transferred to a nitrocellulose filter. The resultant Western blot was 
probed with a mixture of antibodies specific for each of the NF triplet 
proteins. Antibody-antigen complexes  were  visualized  by incubation 
with '251-protein A and subsequent autoradiography (4-day exposure). 
Positions of rat brain NF proteins used as  standards (NF-L, NF-M, 
and  NF-H) are indicated at  the left. 
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FIG. 2. Northern blot analysis of NF subunit mRNA levels  in PC-12 cells. A, RNA (400 ng of mRNA) 
from control  PC-12 cells (0 day)  or cells maintained for 1,4,  or 14  days in NGF, as well as  total RNA (20 pg) from 
15-day-old rat brain, were fractionated on  a formaldehyde-agarose gel and  transferred  to a nylon membrane. The 
resultant  Northern blot was successively hybridized with  32P-labeled  probes to mouse NF-L,  NF-M,  NF-H, and 
actin. Filters were exposed to x-ray film for 1-6 days. B, relative  changes in  NF  subunit mRNA levels with  time 
of exposure to  NGF were quantified by laser densitometry  and normalized with respect to  actin mRNA levels, 
which remained almost  constant over the 14-day period. NF-L mRNA levels represent the sum of both mRNA 
variants. 
the level of NF-L mRNA. Similarly, NGF treatment also 
resulted  in increased levels of NF-M mRNA. However, NF- 
H mRNA levels did not increase in response to  NGF-treat- 
ment.  The  NGF effects were quantified by densitometry (Fig. 
2B). After 14 days of treatment  with  NGF,  total  NF-L  mRNA 
levels (ie. the  sum of both  the 2.5- and 4.0-kb species) had 
increased 14-fold and NF-M mRNA 12-fold over control 
levels. The  time course of NF-L  and  NF-M  mRNA  induction 
differed in  that while NF-L mRNA levels increased almost 
linearly over 14 days, NF-M mRNA increased much more 
rapidly so that by 4 days of NGF  treatment  almost 90% of 
the maximal level had been reached. The level of NF-H 
mRNA did not increase and may have  declined  slightly after 
14  days of NGF  treatment.  These  results  indicated  that  NGF 
had a different effect on  the expression of NF-H as compared 
to  the two  smaller subunits.  Both  mRNA  and  protein levels 
increased in parallel  with NGF  treatment  with  NF-L  and  NF- 
M  whereas the increase in  NF-H was not accompanied by an 
increase in  the corresponding mRNA. 
To  better assess the effect that  NGF  exerts  on  the levels of 
various NF mRNAs in PC-12 cells, we made  use of the nuclear 
run-off assay to measure the  transcriptional  activity of the 
NF genes in control and NGF-treated cells. The  results  in 
Fig. 3 show that  NGF  treatment resulted in increased tran- 
scription of the  NF-L  and  NF-M genes but  little or no increase 
in  the  transcription  rate of NF-H.  Densitometry of the  auto- 
radiograph showed approximately 4- and 5-fold increases in 
NF-L and NF-M gene expression, respectively (data not 
shown).  Actin gene transcription represented  a control for a 
gene that does not respond  greatly to  NGF  treatment (47). 
s can be seen in Fig. 3, actin gene transcription was increased 
only  slightly, about 1.5-2 times over control levels in response 
to NGF. The specificity of the assay was tested by checking 
for  spurious  hybridization to plasmid vectors. As can be seen 
in Fig. 3, no such hybridization could be detected. 
To examine the question of whether NGF increases  steady 
state levels of NF-L  and  NF-M mRNA by also  increasing the 
stability of these  transcripts, PC-12 cells grown in control or 
NGF-supplemented medium were exposed to ACTD, a potent 
inhibitor of mRNA  synthesis. The RNA from cells maintained 
for  various times  up  to 25 h in  the presence of ACTD was 
subjected to  Northern blot  analysis and  the results are shown 
in Fig. 4. For  the purpose of the analysis, total  NF-L mRNA 
levels were taken  to be the sum of both  NF-L mRNA species 
(2.5 and 4.0 kb). Despite the differences in the absolute 
amounts of NF-L mRNA between PC-12 cells treated with 
NGF  and  control cells (Fig. 4A), densitometric  analysis (Fig. 
4B) showed little if any difference in  the relative half-lives of 
total NF-L mRNA. In contrast to total NF-L mRNA, the 
half-life of NF-M mRNA in PC-12 cells was increased signif- 
icantly by NGF treatment (Fig. 4C), from about 10 h in 
control cells to 17 h in  NGF-treated cells. The  faint signal 
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FIG. 3. Analysis of NF subunit gene transcription in control 
or NGF-treated PC-12 cells. Plasmid DNAs containing cDNA 
inserts for each of the NF genes or actin, as well as pUC18 and 
pBR322 DNA were bound to nitrocellulose  filters and hybridized to 
32P-labeled mRNA run-off transcripts (1 X lo7 cpm/ml) isolated from 
nuclei of control cells or cells maintained  in  NGF  as described under 
"Materials and Methods." Filters were exposed to x-ray film for 2 
days. 
observed for NF-H mRNA in  either control or NGF-treated 
PC-12 cells (Fig. 4A) precluded densitometric analysis, but 
there appeared to be little difference in its relative stability. 
Since all hybridizations were performed on the same Northern 
blot, the effect of NGF on the stability of NF-M mRNA 
appeared specific and limited to  the mRNA for this  subunit 
only. Thus,  it  appears  that  NGF  acts  to increase NF-L mRNA 
levels in PC-12 cells primarily by increasing the  transcription 
rate of the NF-L gene. In the case of NF-M mRNA the 
increased steady state levels appear  to be due to increases 
both in the transcription rate of the NF-M gene and the 
stability of NF-M mRNA. Since  steady state  NF-H mRNA 
levels in PC-12 cells do not  appear  to respond to NGF  admin- 
istration,  the increase in  NF-H  subunit expression may be 
due to a  post-transcriptional or translational effect. 
DISCUSSION 
We and  others have shown that PC-12 cells show a  time- 
dependent  increase  in NF  content when treated with NGF 
(28-31,58). Increases in  NF-L  and NF-M occurred relatively 
quickly and in parallel becoming detectable after 1 day in 
NGF and approaching maximum levels after 4 days. In this 
report we show that NF-H biosynthesis does not respond 
similarly to NGF. The increase in  NF-H  content was much 
slower as readily detectable amounts were only seen after 14 
days of treatment with NGF. This differential expression of 
NF-L  and  NF-M  as compared to  NF-H  in PC-12 cells has 
also been observed in developing rat  brain  and  other in uiuo 
systems (19-21). 
Previous work has  demonstrated  that  NGF  treatment of 
PC-12 cells results in increased levels of NF-L mRNA and 
that  this increase is due to increased transcription of the gene 
(46). We have confirmed and extended these findings by 
showing that a  similar  increase in  the level of NF-M mRNA 
with  NGF treatment was also  due to increased transcription. 
Thus,  the  NF-L  and  NF-M genes behave similarly in  their 
response to NGF, both at  the  transcriptional level and  at  the 
level of expression. However, while NGF  treatment does not 
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FIG. 4. Relative  stability of NF subunit mRNA in control or 
NGF-treated PC-12 cells. A, PC-12 cells grown in  the absence or 
presence of NGF were exposed to ACTD (5 rg/ml) for 0,5,10, 15, or 
25 h. At  these  times RNA was purified and subjected to  Northern 
analysis as previously described. Northern blots were hybridized with 
"P-labeled cDNA probes to  NF subunits. Filters were exposed to film 
for 1-5 days. B, decreases in  the levels of NF-L mRNA in cells grown 
in  the absence or presence of NGF with time of exposure to ACTD 
were quantified by laser  densitometry. The relative amounts of 
mRNA at each time  point  represent  the  sum of both NF-L species 
and  are expressed as a  percentage of mRNA levels at  0 time (100%). 
C, analysis  performed as in B for NF-M mRNA. 
modulate the stability of NF-L mRNA to a significant degree, 
it does appear to stabilize NF-M mRNA. This may account 
for the more rapid rise in  NF-M mRNA levels after admin- 
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istration of NGF. 
In other systems, stabilization of mRNA has been shown 
to be  of importance in the superinduction of c-fos mRNA by 
inhibitors of protein synthesis, although the mechanism is 
unknown (48). Glucocorticoid regulation of growth hormone 
mRNA levels may also depend on mRNA stabilization, in  this 
case through the induction of a stabilizing protein  as well as 
by an increased extent of polyadenylation of mRNA (49). 
This  latter mechanism has been demonstrated to increase the 
stability of viral mRNA (60). A -50 nucleotide long AU-rich 
sequence in the 3’-noncoding region has been shown to confer 
instability to various mammalian mRNAs (61). As well, the 
regulation of 8-tubulin mRNA stability has been linked to a 
-100 nucleotide long translated region at  the 5’ end of the 
mRNA (62). The mechanism for the stabilization of NF-M 
mRNA by NGF in PC-12 cells is not known, nor is it clear 
why this effect is specific for NF-M mRNA and  not for mRNA 
of the  other two subunits. Since NF-M protein  is  transiently 
expressed in a subpopulation of chick neuron precursors (50), 
it does not seem that co-expression or co-regulation of NF-L 
and  NF-M is obligatory. 
NGF did not increase NF-H mRNA levels over the period 
examined (14 days), nor did NGF increase transcription of 
the NF-H gene. These findings emphasize the distinct  nature 
of both the  NF-H subunit  and the  NF-H gene. Perhaps  the 
difference in  the regulation of the  NF-H expression reflects 
the unique properties of NF-H in the axon. It has been shown, 
for example, that  the appearance of NF-H in the axon results 
in an %fold decrease in  the rate of the slow component of 
axonal transport (20). NF-H  has also been demonstrated to 
be a component of the cross-bridging structures found in the 
axon (20, 51-54). These and other observations have  led to 
the hypothesis that  NF-H may serve to stabilize the axonal 
cytoskeleton (20, 54). If this  is  the case, then expression of 
NF-H  during early stages of neuronal growth and develop- 
ment may  prove detrimental to axonal growth and/or plastic- 
ity. 
Although NGF  treatment of PC-12 cells did not  result in 
increased levels of NF-H mRNA, a slow but significant in- 
crease in NF-H immunoreactivity was observed over 14 days 
of NGF treatment.  This may reflect control of NF-H expres- 
sion in PC-12 cells at the post-transcriptional level. Such a 
mechanism has been demonstrated to exist for controlling the 
expression of a keratin subtype in hyperproliferative skin 
cells (55). Alternatively, NGF may act  post-translationally to 
increase the metabolic stability of the NF-H polypeptide in 
PC-12 cells, as  has been shown for NF-L  and  NF-M  subunits 
(31). Since a correlation has been shown between the extent 
of NF subunit phosphorylation and resistance to degradation 
(56), NGF may render NF-H more stable by increasing its 
phosphorylation level (31). In  this regard, it should be noted 
that  the  NF-H immunoreactivity observed on Western blots 
after prolonged NGF  treatment consists of multiple bands, 
indicating a multiplicity of phosphorylation states (31). 
PC-12 cells express fairly low levels of NF-H when com- 
pared, for example, to cultured peripheral neurons derived 
from neonatal  rat (30). PC-12 cells have also been shown to 
express other  intermediate filament proteins, such as vimen- 
tin (29), cytokeratins (57), and  a novel 57-kDA intermediate 
filament protein that is also NGF-inducible (58). It is not 
clear whether these examples indicate that NF expression in 
PC-12 cells is abnormal, as previously suggested (29, 30), but 
it is interesting to note that  the delayed expression of NF-H 
after  NGF  treatment is similar to  the in vivo developmental 
pattern of NF subunit expression (19-21). Neurons comprise 
a diverse set of cells, which, unlike PC-12 cells, may be 
exposed to many external cues in uiuo. NGF alone may not 
be sufficient to induce substantial levels of NF-H in PC-12 
cells. Other factors in the extracellular environment, includ- 
ing cell-cell interactions, may also have to be considered in 
this regard. 
It is clear from these studies and previous ones (31) that 
NGF-induced differentiation is a complex process, having 
both  transcription-dependent  and independent phases (59). 
Transcription-dependent processes can be divided into  short 
term responses, taking place  over a few minutes or hours, and 
long term responses, occurring after many hours or even days 
(27). It is the long term NGF-induced responses that are 
associated with the acquisition of the neuronal phenotype in 
PC-12 cells (27). However, it is presently not known what cis- 
or trans-acting factors, in concert with NGF, may  be  involved 
in the regulation of this developmental program. In  uitro 
experiments designed to analyze the regulatory domains of 
the  NF subunit genes may provide the means to address this 
question directly. 
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